Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms, Carcinoma, Neoplasms, Adenocarcinoma, Ovarian Epithelial Carcinoma, Serous Cystadenocarcinoma, Paclitaxel, Carboplatin, Oregovomab
Lead Scientist at University of California Health
- Ramez Eskander, MD (ucsd)
Associate Clinical Professor, Ob/Gyn & Reproductive sciences, Vc-health Sciences-schools. Authored (or co-authored) 85 research publications
- accepting new patients
- Start Date
- Completion Date
- CanariaBio Inc.
- Phase 3 research study
- Study Type
- Expecting 602 study participants
- Last Updated